Chemoinformaics analysis of Pterosin D 3-O-glucoside
| Molecular Weight | 410.463 | nRot | 5 |
| Heavy Atom Molecular Weight | 380.223 | nRig | 17 |
| Exact Molecular Weight | 410.194 | nRing | 3 |
| Solubility: LogS | -1.917 | nHRing | 1 |
| Solubility: LogP | 0.72 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 61.4898 |
| nHD | 5 | BPOL | 34.4362 |
| QED | 0.455 |
| Synth | 4.452 |
| Natural Product Likeliness | 2.211 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.023 |
| Pgp-sub | 0.84 |
| HIA | 0.835 |
| CACO-2 | -5.397 |
| MDCK | 0.000011 |
| BBB | 0.163 |
| PPB | 0.767182 |
| VDSS | 1.159 |
| FU | 0.207327 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.104 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.557 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.091 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.143 |
| CL | 1.688 |
| T12 | 0.531 |
| hERG | 0.023 |
| Ames | 0.816 |
| ROA | 0.078 |
| SkinSen | 0.199 |
| Carcinogencity | 0.039 |
| EI | 0.017 |
| Respiratory | 0.034 |
| NR-Aromatase | 0.651 |
| Antiviral | No |
| Prediction | 0.537223 |